A Relentless Downtrend
• CRO has now produced 10 consecutive lower monthly closes, highlighting the persistence of the current downtrend.
• Since the August 2025 high, price has declined approximately 84%.
Major Monthly Support Under Test
• Price has fallen back into a support zone that has repeatedly attracted buyers since 2020.
• Previous lows at $0.0537, $0.0476 and the recent $0.0553 low all sit within this region.
Buyers Finally Showing Up
• After printing a fresh low at $0.0553, CRO has managed to produce a modest reaction from support.
• For now, this looks more like a relief bounce than a confirmed reversal.
Resistance Remains Overhead
• Initial Resistance sits around $0.067, which previously acted as support before the breakdown.
• Above that, the $0.081-$0.083 region remains the next major hurdle for bulls.
Momentum Still Favours The Bears
• RSI remains below 50 on both the daily and monthly timeframes.
• While short-term momentum has improved slightly, the broader picture remains weak.
A Critical Moment For CRO
• This support zone has historically produced significant reversals and remains one of the most important levels on the chart.
• If buyers fail to defend it, attention is likely to shift towards the historic 2020 lows.
Summary
CRO is testing one of the most important support zones in its history after declining 84% from the August 2025 high. Ten consecutive lower monthly closes underline the severity of the downtrend, while price now sits at a level that has repeatedly attracted buyers over the past several years. A relief rally from this area would not be surprising, but the broader trend remains weak. The coming weeks could prove pivotal in determining whether support holds or another major leg lower develops.
• CRO has now produced 10 consecutive lower monthly closes, highlighting the persistence of the current downtrend.
• Since the August 2025 high, price has declined approximately 84%.
Major Monthly Support Under Test
• Price has fallen back into a support zone that has repeatedly attracted buyers since 2020.
• Previous lows at $0.0537, $0.0476 and the recent $0.0553 low all sit within this region.
Buyers Finally Showing Up
• After printing a fresh low at $0.0553, CRO has managed to produce a modest reaction from support.
• For now, this looks more like a relief bounce than a confirmed reversal.
Resistance Remains Overhead
• Initial Resistance sits around $0.067, which previously acted as support before the breakdown.
• Above that, the $0.081-$0.083 region remains the next major hurdle for bulls.
Momentum Still Favours The Bears
• RSI remains below 50 on both the daily and monthly timeframes.
• While short-term momentum has improved slightly, the broader picture remains weak.
A Critical Moment For CRO
• This support zone has historically produced significant reversals and remains one of the most important levels on the chart.
• If buyers fail to defend it, attention is likely to shift towards the historic 2020 lows.
Summary
CRO is testing one of the most important support zones in its history after declining 84% from the August 2025 high. Ten consecutive lower monthly closes underline the severity of the downtrend, while price now sits at a level that has repeatedly attracted buyers over the past several years. A relief rally from this area would not be surprising, but the broader trend remains weak. The coming weeks could prove pivotal in determining whether support holds or another major leg lower develops.
I analyse markets by observing levels, patterns, and structure. I share my process and reasoning for educational purposes, helping readers understand market behaviour without giving advice or predictions.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
I analyse markets by observing levels, patterns, and structure. I share my process and reasoning for educational purposes, helping readers understand market behaviour without giving advice or predictions.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.